Back

Harbour BioMed joins Stock Connect after surpassing HK$10 billion market cap

Verifying
  • Harbour BioMed shares entered the Stock Connect eligible list on Sept. 6, 2026.
  • US$122.5 million was first-half revenue, up 20.9% year over year.
  • Harbour BioMed has nearly 30 drug candidates across four therapeutic areas.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.